Markell M S, Friedman E A
Department of Medicine, SUNY Health Science Center, Brooklyn 11203.
Semin Nephrol. 1990 May;10(3):274-86.
Diabetic nephropathy is now the leading cause of renal failure in patients referred for uremia therapy. The diabetic patient is a complicated treatment problem from the first detection of microalbuminmuria, at which time decisions regarding choice of antihypertensive and strictness of metabolic control assume increasing importance. At present, our policy is to advocate strict control of blood pressure, aiming for a systolic blood pressure of less than 140 mm Hg and a diastolic blood pressure of less than 80 mm Hg. We attempt to maintain hemoglobin Alc levels at less than 8%, if the patient does not develop frequent episodes of hypoglycemia. We extend these recommendations to the patient with frank proteinuria, nephrotic syndrome and early uremia, understanding that strict metabolic control may be impossible as patients lose GFR. In addition, we recommend avoidance of a high protein diet in the early nephropathic diabetic, with diet of approximately 1 gm/kg/d. As renal failure progresses, we embark on an analysis of the patient's abilities, lifestyle, and social support. At a GFR of approximately 10 mL/min, we initiate preparations for uremia therapy. If a willing and appropriate living related kidney donor is available, the patient is referred for cardiovascular evaluation and kidney transplantation performed subsequently. If no donor is immediately available, we refer the patient for vascular access placement and/or insertion of a Tenckhoff peritoneal catheter, if preferred. Most of these predialysis patients also undergo screening for placement on the cadaveric kidney transplant list, including cardiac work-up as is done for the patients who receive living-related renal transplants. Because of the long waiting list in Brooklyn, and the universal shortage of organ donors, many of these patients eventually end up on dialysis for some period of time. Other extrarenal problems (urologic, ophthalmologic) are addressed at initial referral and followed up, in hopes of maintaining the patient in optimal physical shape as uremia progresses. The care of the diabetic patient with ESRD ideally involves a consortium of caregivers. We include a nurse-educator familiar with options for uremia therapy, a podiatrist, a cardiologist, and often a urologist, an endocrinologist, and a gastroenterologist. In addition, a social worker is helpful to assess psychologic difficulties in adjustment to uremia, socioeconomic considerations, and rehabilitation status. Finally, the nephrologist, as coordinator of this team works with the vascular or transplant surgeon, to facilitate the transition to ESRD and its therapy.
糖尿病肾病现已成为接受尿毒症治疗患者肾衰竭的首要原因。从首次检测到微量白蛋白尿起,糖尿病患者就是一个复杂的治疗难题,此时关于选择降压药和严格控制代谢的决策变得愈发重要。目前,我们的策略是提倡严格控制血压,目标是收缩压低于140毫米汞柱,舒张压低于80毫米汞柱。如果患者未频繁发生低血糖,我们试图将糖化血红蛋白水平维持在8%以下。对于出现明显蛋白尿、肾病综合征和早期尿毒症的患者,我们也给出这些建议,因为我们明白随着患者肾小球滤过率下降,可能无法进行严格的代谢控制。此外,我们建议早期肾病性糖尿病患者避免高蛋白饮食,饮食量约为1克/千克/天。随着肾衰竭进展,我们会对患者的能力、生活方式和社会支持进行分析。当肾小球滤过率约为10毫升/分钟时,我们开始为尿毒症治疗做准备。如果有意愿且合适的活体亲属肾供体,患者会被转介进行心血管评估,随后进行肾脏移植。如果没有立即可用的供体,我们会根据患者的意愿,将其转介进行血管通路置入和/或插入Tenckhoff腹膜透析导管。大多数这些透析前患者也会接受筛查,以列入尸体肾移植名单,包括像接受活体亲属肾移植的患者那样进行心脏检查。由于布鲁克林的等待名单很长,且器官供体普遍短缺,许多这些患者最终会有一段时间接受透析治疗。其他肾外问题(泌尿外科、眼科)在初次转诊时就会得到处理并进行随访,以期在尿毒症进展过程中让患者保持最佳身体状态。理想情况下,对终末期肾病糖尿病患者的护理需要一个护理团队。我们的团队包括一名熟悉尿毒症治疗选择的护士教育者、一名足病医生、一名心脏病专家,通常还有一名泌尿外科医生、一名内分泌科医生和一名胃肠病专家。此外,一名社会工作者有助于评估患者在适应尿毒症过程中的心理困难、社会经济因素和康复状况。最后,作为该团队协调人的肾病专家会与血管外科医生或移植外科医生合作,以促进向终末期肾病及其治疗的过渡。